TickerFacts.

Niagen Bioscience, Inc. (NAGE): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

85.44M
Year ended 2025-12-31
+7.0%
3-year compound annual growth
+6.9%
5-year compound annual growth
100.59M2011-01-01: 48.25M2011-12-31: 75.98M2012-12-29: 95.99M2013-12-28: 100.59M2020-12-31: 61.07M2021-12-31: 67.19M2022-12-31: 69.73M2023-12-31: 74.98M2024-12-31: 78.12M2025-12-31: 85.44M85.44M
2011-01-01 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3185.44M+9.4%2026-03-04, From 2025-01-01
2024-12-3178.12M+4.2%2026-03-04, From 2024-01-01
2023-12-3174.98M+7.5%2025-03-04, From 2023-01-01
2022-12-3169.73M+3.8%2024-03-06, From 2022-01-01
2021-12-3167.19M+10.0%2023-03-08, From 2021-01-01
2020-12-3161.07Mn/a2022-03-14, From 2020-01-01
No annual figure between 2013-12-28 and 2020-12-31.
2013-12-28100.59M+4.8%2014-03-27, From 2012-12-30
2012-12-2995.99M+26.3%2014-03-27, From 2012-01-01
2011-12-3175.98Mn/c2013-03-29, From 2011-01-02
2011-01-01, Fiscal 201048.25Mn/a2012-03-15, From 2010-01-03